Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.186,54
-0,88%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Akoya BioSciences Inc (AKYA) Akoya BioSciences Inc (AKYA) Notizie

Akoya BioSciences Inc

AKYA
3,80
-0,02 (-0,52%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202422:05GLOBEAkoya to Report First Quarter 2024 Financial Results on May..
05/4/202414:00GLOBEAkoya Biosciences Showcases Spatial Biology 2.0 Solutions at..
04/3/202423:18EDGAR2Form 8-K - Current report
04/3/202422:05GLOBEAkoya Reports Record Revenue in the Fourth Quarter of 2023..
04/3/202412:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
02/3/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05GLOBEAkoya to Report Fourth Quarter and Full Year 2023 Financial..
18/1/202414:00GLOBEAkoya Biosciences’ Technology Enables Queensland Spatial..
10/1/202422:02EDGAR2Form 8-K - Current report
10/1/202414:00GLOBEAkoya Biosciences Announces that Garry Nolan, Ph.D., James..
08/1/202421:57DJNAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher..
08/1/202412:02EDGAR2Form 8-K - Current report
07/1/202414:00GLOBEAkoya Biosciences Announces Preliminary Financial Results..
03/1/202414:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202301:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202314:05GLOBEAkoya to Participate at 42nd Annual J.P. Morgan Healthcare..
19/12/202322:23EDGAR2Form 144 - Report of proposed sale of securities
14/12/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202300:33EDGAR2Form 144 - Report of proposed sale of securities
27/11/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:37EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:06EDGAR2Form 8-K - Current report
08/11/202322:00GLOBEAkoya Reports Record Revenue in the Third Quarter of 2023..
02/11/202313:00GLOBEAkoya to Participate at Three Upcoming Investor Conferences
31/10/202314:00GLOBEAkoya Biosciences to Showcase New Spatial Biology 2.0..
17/10/202316:22GLOBEAkoya Biosciences Announces Peer-Reviewed Publication Using..
11/10/202322:05GLOBEAkoya to Report Third Quarter 2023 Financial Results on..
19/9/202314:00GLOBEAkoya Biosciences Sets a New Standard for Scaling Spatial..
06/9/202322:01EDGAR2Form 8-K - Current report
07/8/202322:10EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEAkoya Reports Record Revenue in the Second Quarter of 2023..
07/8/202314:05GLOBEAkoya Biosciences Announces Milestone of 1,000 Peer-Reviewed..
26/7/202322:05GLOBEAkoya to Participate at Three Upcoming Investor Conferences
13/7/202323:10EDGAR2Form 144 - Report of proposed sale of securities
13/7/202300:28EDGAR2Form 144 - Report of proposed sale of securities
12/7/202314:05GLOBEAkoya to Report Second Quarter 2023 Financial Results on..
05/7/202322:05EDGAR2Form 8-K - Current report
28/6/202323:18EDGAR2Form 8-K - Current report
12/6/202322:05GLOBEAkoya to Participate at Two Upcoming Investor Conferences
08/6/202306:55GLOBEAkoya Biosciences Announces Pricing of Public Offering of..
08/6/202302:08DJNAkoya Biosciences Shares Fall on Executive Exits, Stock..
07/6/202322:08GLOBEAkoya Biosciences Announces Public Offering of Common Stock
08/5/202322:05GLOBEAkoya Reports Record Revenue in the First Quarter of 2023..
Apertura: 3,80 Min: 3,745 Max: 3,84
Chiusura: 3,82

La tua Cronologia

NASDAQ
AKYA
Akoya BioSciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network